J. de Juan-‐Sanz & col.
448
16. Kamei D.; Yamakawa K.; Takegoshi Y.; Mikami-‐Nakanishi M.; Nakatani Y.; Oh-‐Ishi S.; Yasui
H.; Azuma Y.; Hirasawa N.; Ohuchi K.; Kawaguchi H.; Ishikawa Y.; Ishii T.; Uematsu S.; Akira
S.; Murakami M.; Kudo I. Reduced pain hypersensitivity and inflammation in mice lacking
microsomal prostaglandin e synthase-‐1. J. Biol. Chem. 279, 33684-‐33695 (2004).
17. Mabuchi T.; Kojima H.; Abe T.; Takagi K.; Sakurai M.; Ohmiya Y.; Uematsu S.; Akira S.;
Watanabe K.; Ito S. Membrane-‐associated prostaglandin E synthase-‐1 is required for
neuropathic pain. Neuroreport 15, 1395-‐1398 (2004).
18. Harvey R.J.; Depner U.B.; Wässle H.; Ahmadi S.; Heindl C.; Reinold H.; Smart T.G.; Harvey K.;
Schütz B.; Abo-‐Salem O.M.; Zimmer A.; Poisbeau P.; Welzl H.; Wolfer D.P.; Betz H.; Zeilhofer
H.U.; Müller U. GlyR α3: an essential target for spinal PGE2-‐mediated inflammatory pain
sensitization. Science. 304, 884–7 (2004).
19. Reinold H.; Ahmadi S.; Depner U.B.; Layh B.; Heindl C.; Hamza M.; Pahl A.; Brune K.;
Narumiya S.; Müller U.; Zeilhofer H.U. Spinal inflammatory hyperalgesia is mediated by
prostaglandin E receptors of the EP2 subtype. J. Clin. Invest. 115, 673–9 (2005).
20. Malmberg A. B.; Brandon E. P.; Idzerda R. L.; Liu H.; McKnight G. S.; Basbaum A. I.
Diminished inflammation and nociceptive pain with preservation of neuropathic pain in
mice with a targeted mutation of the type I regulatory subunit of cAMP-‐dependent protein
kinase. J. Neurosci. 17, 746-‐7470 (1997).
21. Gomeza J.; Ohno K.; Hülsmann S.; Armsen W.; Eulenburg V.; Richter D.W.; Laube B.; Betz H.
Deletion of the mouse glycine transporter 2 results in a hyperekplexia phenotype and
postnatal lethality. Neuron. 40, 797-‐806 (2003).
22. Donaldson L.F.; Humphrey P.S.; Oldfield S.; Giblett S.; Grubb B.D. Expression and regulation
of prostaglandin E receptor subtype mRNAs in rat sensory ganglia and spinal cord in
response to peripheral inflammation. Prostaglandins. Other. Lipid. Mediat. 63, 109-‐22
(2001).
23. Mebane H.; Turnbach M.E.; Randich A. Spinal EP receptors mediating prostaglandin E2-‐
induced mechanical hyperalgesia, thermal hyperalgesia, and touch-‐evoked allodynia in
rats. J. Pain. 4, 392-‐9 (2003).
24. Breyer R.M.; Bagdassarian C.K.; Myers S.A.; Breyer M.D. Prostanoid receptors: subtypes and
signaling. Annu. Rev. Pharmacol. Toxicol. 41, 661-‐90 (2001).
25. Narumiya S.; Sugimoto Y.; Ushikubi F. Prostanoid receptors: structures, properties, and
functions. Physiol. Rev. 79, 1193-‐226 (1999).
26. Singh P.; Hoggatt J.; Hu P.; Speth JM.; Fukuda S.; Breyer RM.; Pelus LM. Blockade of
prostaglandin E2 signaling through EP1 and EP3 receptors attenuates Flt3L-‐dependent
dendritic cell development from hematopoietic progenitor cells. Blood. 119, 1671-‐82
(2012).
27. Iwanaga K.; Okada M.; Murata T.; Hori M.; Ozaki H. Prostaglandin E2 promotes wound-‐
induced migration of intestinal subepithelial myofibroblasts via EP2, EP3, and EP4
prostanoid receptor activation. J. Pharmacol. Exp. Ther. 340, 604-‐11(2012).
28. Furuyashiki T.; Narumiya S. Stress responses: the contribution of prostaglandin E(2) and
its receptors. Nat. Rev. Endocrinol. 7, 163-‐75 (2011).
29. Clasadonte J.; Poulain P.; Hanchate NK.; Corfas G.; Ojeda S.R.; Prevot V. Prostaglandin E2
release from astrocytes triggers gonadotropin-‐releasing hormone (GnRH) neuron firing
via EP2 receptor activation. Proc. Natl. Acad. Sci. USA. 108, 16104-‐9 (2011).
30. Ushikubi F.; Segi E.; Sugimoto Y.; Murata T.; Matsuoka T.; Kobayashi T.; Hizaki H.; Tuboi K.;
Katsuyama M.; Ichikawa A.; Tanaka T.; Yoshida N.; Narumiya S. Impaired febrile response
in mice lacking the prostaglandin E receptor subtype EP3. Nature. 395, 281-‐4 (1998).
31. Matsuoka Y.; Furuyashiki T.; Yamada K.; Nagai T.; Bito H.; Tanaka Y.; Kitaoka S.; Ushikubi F.;
Nabeshima T.; Narumiya S. Prostaglandin E receptor EP1 controls impulsive behavior
under stress. Proc. Natl. Acad. Sci. USA. 102, 16066-‐71 (2005).
